透過您的圖書館登入
IP:3.15.226.173
  • 期刊

施打子宮頸癌疫苗應有的認識

Prevention of Cervical Cancer with Vaccination

摘要


子宮頸癌是國內女性癌症發生率的第一位,近年來醫界已成功的發展子宮頸癌疫苗,可大大的降低子宮頸癌的發生率;歐美先進國家已採常規接種,而國內亦於2007年核准上市,身爲醫護人員的我們對此疫苗亦應有更進一步認識的必要,故筆者將子宮頸癌相關文獻作整理,內容包含子宮頸癌疫苗的發展過程、作用機轉、當前上市的子宮頸癌疫苗相關資訊之比較以及施打子宮頸癌疫苗照護的注意事項等,經由文獻的探討我們建議施打疫苗的民眾,施打前應對此疫苗有正確且完整的認知,子宮頸疫苗方能完整的發揮成效,若要防止子宮頸癌的發生除了施打子宮頸疫苗外,最重要的仍須依醫師指示確實抹片檢查以及安全的性行爲(使用避孕套)。最後如何提供民眾正確且完整的資訊,端賴政府以及醫療相關人員是否能全面性的宣導與教育,假若每一位施打的民眾均能瞭解施打子宮頸癌疫苗應注意的相關事項,並能依建議確實遵循,相信國內子宮頸癌之發生率大幅降低是指日可待的。

並列摘要


Cervical cancer has been the most prevalent cancer of female genital tract in Taiwan. The mortality rates will likely decline in the future because of the introduction of the Human Papillomavirus (HPV) vaccine. The vaccine will possibly have prophylactic or even treatment effect for invasive cervical cancer as well as its obligate precursor, cervical intraepithelial neoplasia. Some western countries have launched HPV vaccination program on a regular basis. Taiwan's Department of Health approved the HPV vaccine in 2007. As health care professionals, it is important for us to have better knowledge about the vaccine. In this article we reviewed the development and usage of the vaccine and compared different vaccines that have been introduced. We recommend that in order to prevent the disease, sufficient information should be provided to the public, vaccination and regular cervical smear program need to be promoted, and practice of safe sex with condom use needs to be emphasized. If the females to whom the vaccine is administered have right attitude regarding the use of the vaccine and follow the recommendations and instructions of health care professionals, it is possible that the incidence rate of cervical cancer could reduce eventually.

並列關鍵字

cervical cancer human papillomavirus vaccine

延伸閱讀